The global infusion therapy devices market is anticipated to grow at a considerable CAGR of 7.8% during the forecast period(2022-2028). Infusion therapy has become a popular pain relief treatment method, especially for diseases where oral medication is the least effective. The infusion therapy is equally effective in treating disorders such as cystic fibrosis, and chronic dehydration. Thus the rising number of cystic fibrosis, and chronic dehydration in the emerging economies is the major driving factor that boosts the global infusion therapy devices market.
For instance, according to American Lung Association in March 2020, there are about 30,000 people with cystic fibrosis in the United States and approximately 70,000 people worldwide. Approximately 1 in 30 Americans is a carrier. Moreover, a report published by Cystic Fibrosis Foundation, shows that In 2019, there were 31,199 individuals with CF in the Registry. The number of adults with CF continues to increase, while the number of children remains relatively stable. In 2019, adults were 56.0 percent of the CF population.
A full report of Infusion Therapy Devices Market is available at: https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size
These key manufacturers are adopting various strategies like new product launches, mergers and acquisitions, partnerships and collaborations, and many others to thrive in a competitive environment. For instance, in March 2021, Smiths Medical unveiled its partnership with Ivenix on infusion management. Ivenix develops the first and only large volume infusion pump to meet the latest FDA guidelines. The infusion system is equipped with a large volume pump with administration sets, infusion tools, and analytics too. The pump is designed to reduce infusion-related errors and drive down the cost of ownership.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/infusion-therapy-devices-market-size
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- by product type, by application, by end-user
- Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
- Competitive Landscape- B. Braun Melsungen AG, Becton, Dickinson and Co., Medtronic PLC, Novartis AG, Terumo Europe NV,Fresenius SE & Co. KGaA, ICU Medical, Inc., Infuserve America Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Infusion Therapy Devices Market– Segmentation
By Product Type
- Infusion pumps
- Consumables and accessories
By Application
- Oncology
- Diabetes
- Gastroenterology
- Analgesia
- Hematology
- Others(Pediatrics)
By End-User
- Hospitals
- Homecare
- Ambulatory Surgery Centers
